ANIP
ANI Pharmaceuticals, Inc. 9/1/2025, 5:44:30 PM
NasdaqGM
USD
EQUITY
At Close
$93.50
+29.67 (+46.48%)
Volume
283,240
Market Cap
2.03B
NasdaqGM
Period
No AI Analysis Available
Generate a comprehensive AI analysis for ANIP to get insights on valuation, growth prospects, and investment recommendations.
Valuation
-
-
Profitability
-2.2%
1.1%
1.3%
61.1%
2.6%
-1.4%
Growth
38.7%
43.8%
-
-
26.0%
Financial Health
Forward Looking
Strong Buy
$82.89
-
$9.13
Small-Cap
Risk & Technical
0.61
$93.72 / $52.50
81.34
13.0%
Shareholder Returns
-
-
-
-1.0%
6.7%